Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L
About this event
AlphaSense finds information on companies, data and themes from within millions of research documents in seconds, all with ONE simple search. Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L is an official webinar listing associated with AlphaSense. Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions.
UPCOMING provides this independent listing to help professionals discover the session.
What you'll learn
- Adam Griifiths, LSX (Moderator)
- Ed Kivell, Life Sciences lead EMEA/APAC, AlphaSense
- Matthias Mullenbeck, SVP, Head Global Business Development & Alliance Management, Merck
- Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics
- Martin-Immanuel Bittner, Co-Founder and CEO, Arctoris
- Marko Kuisma, Partner, Innovestor
Topics covered
Frequently asked questions
Who is hosting Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L?
Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L is hosted by AlphaSense.
When is Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L?
See the official event page for Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L's confirmed availability and schedule details.
Where does registration take place?
Registration or viewing is completed on AlphaSense's website.
What format is this event?
This is an online webinar.
Which topics does this event cover?
The event covers AI and Data.
